FDA Names Senior Regulatory Counsel As New Reg Chief

FDA names senior regulatory counsel in the Center for Drug Evaluation and Research, Grail Sipes, as the new permanent director of the Office of Regulatory Policy (ORP), the agency announced Monday (Sept. 15). In this position she will coordinate the development of new regulations and policies, including preparing responses to citizen petitions, and manage the center's disclosure responsibilities. Sipes joined FDA in 2011 and has helped draft regulatory and policy documents, including citizen petition responses, regulations and guidances, She was...